1. Junger W G, 2011, Immune cell regulation by autocrine purinergic signaling. Nature Review Immunology, vol.11: 201–212. http://dx.doi.org/10.1038/nri29382. Di Virgilio F, Boeynaems J M and Robson SC, 2009, Extracellular nucleotides as negative modulators of immunity. Current Opinion in Pharmacology, vol.9(4): 507–513. http://dx.doi.org/10.1016/j.coph.2009.06.0213. Idzko M, Ferrari D and Eltzschig H K, 2014, Nucleotide signalling during inflammation. Nature, vol.509: 310–317. http://dx.doi.org/10.1038/nature130854. Lazarowski E R, Boucher R C and Harden T K, 2003, Mechanisms of release of nucleotides and integration of their action as P2X- and P2Y-receptor activating molecules. Molecular Pharmacology, vol.64(4): 785–795. http://dx.doi.org/10.1124/mol.64.4.7855. Boeynaems J M, Communi D, Gonzalez N S, et al. 2005, Overview of the P2 receptors. Seminars in Thrombosis and Hemostasis, vol.31(2): 139–149. http://dx.doi.org/10.1055/s-2005-8695196. Boeynaems J M, Communi D and Robaye B, 2012, Overview of the pharmacology and physiological roles of P2Y receptors. Wiley Interdisciplinary Reviews: Membrane Transport and Signalling, vol.1(5): 581–588. http://dx.doi.org/10.1002/wmts.447. Syed N I H and Kennedy C, 2011, Pharmacology of P2X receptors. Wiley Interdisciplinary Reviews: Membrane Transport and Signalling, vol.1(1): 16–30. http://dx.doi.org/10.1002/wmts.18. Ben Addi A, Cammarata D, Conley P B, et al. 2010, Role of the P2Y12 receptor in the modulation of murine dendritic cell function by ADP. Journal of Immunology, vol.185(10): 5900–5906. http://dx.doi.org/10.4049/jimmunol.09017999. Warny M, Aboudola S, Robson S C, et al. 2001, P2Y6 nucleotide receptor mediates monocyte interleukin-8 production in response to UDP or lipopolysaccharide. Journal of Biological Chemistry, vol.276: 26051–26056. http://dx.doi.org/10.1074/jbc.M10256820010. Bar I, Guns P J, Metallo J, et al. 2008, Knockout mice reveal a role for P2Y6 receptor in macrophages, endothelial cells, and vascular smooth muscle cells. Molecular Pharmacology, vol.74(3): 777–784. http://dx.doi.org/10.1124/mol.108.04690411. Kukulski F, Ben Yebdri F, Lefebvre J, et al. 2007, Extracellular nucleotides mediate LPS-induced neutrophil migration in vitro and in vivo. Journal of Leukocyte Biology, vol.81(5): 1269–1275. http://dx.doi.org/10.1189/jlb.120675812. Ben Yebdri F, Kukulski F, Tremblay A, et al. 2009, Concomitant activation of P2Y2 and P2Y6 receptors on monocytes is required for TLR1/2-induced neutrophil migration by regulating IL-8 secretion. European Journal of Immunology, vol.39(10): 2885–2894. http://dx.doi.org/10.1002/eji.20093934713. Koizumi S, Shigemoto-Mogami Y, Nasu-Tada K, et al. 2007, UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis. Nature, vol.446: 1091–1095. http://dx.doi.org/10.1038/nature0570414. Inoue K., Koizumi S, Kataoka A, et al. 2009, P2Y6-evoked microglial phagocytosis. International Review of Neurobiology, vol.85: 159–163. http://dx.doi.org/10.1016/S0074-7742(09)85012-515. Grbic D M, Degagné É, Langlois C, et al. 2008, Intestinal inflammation increases the expression of the P2Y6 receptor on epithelial cells and the release of CXC chemokine ligand 8 by UDP. Journal of Immunology, vol.180(4): 2659–2668. http://dx.doi.org/10.4049/jimmunol.180.4.265916. Grbic D M, Degagné É, Larrivée J F, et al. 2012, P2Y6 receptor contributes to neutrophil recruitment to inflamed intestinal mucosa by increasing CXC chemokine ligand 8 expression in an AP-1-dependent manner in epithelial cells. Inflammatory Bowel Diseases, vol.18(8): 1456–1469. http://dx.doi.org/10.1002/ibd.2193117. Hansen A, Alston L, Tulk S E, et al. 2013, The P2Y6 Receptor mediates Clostridium difficile toxin-induced CXCL8/IL-8 production and intestinal epithelial barrier dysfunction. PLoS ONE, vol.8(11): e81491. http://dx.doi.org/10.1371/journal.pone.008149118. Khine A A, Del Sorbo L, Vaschetto R, et al. 2006, Human neutrophil peptides induce interleukin-8 production through the P2Y6 signaling pathway. Blood, vol.107: 2936–2942. http://dx.doi.org/10.1182/blood-2005-06-231419. Vieira R P, Müller T, Grimm M, et al. 2011, P2Y6 receptor contributes to airway inflammation and remodeling in experimental allergic airway inflammation. American Journal of Respiratory and Critical Care Medicine, vol.184(2): 215–223. http://dx.doi.org/10.1164/rccm.201011-1762OC20. Uratsuji H, Tada Y, Kawashima T, et al. 2012, P2Y6 receptor signaling pathway mediates inflammatory responses induced by monosodium urate crystals. Journal of Immunology, vol.188(1): 436–444. http://dx.doi.org/10.4049/jimmunol.100374621. Kim B, Jeong H, Kim J, et al. 2011, Uridine 5′-diphosphate induces chemokine expression in microglia and astrocytes through activation of the P2Y6 receptor. Journal of Immunology, vol.186(6): 3701–3709. http://dx.doi.org/10.4049/jimmunol.100021222. Riegel A K, Faigle M, Zug S, et al. 2011, Selective induction of endothelial P2Y6 nucleotide receptor promotes vascular inflammation. Blood, vol.117: 2548–2555. http://dx.doi.org/10.1182/blood-2010-10-31395723. Marriott I, Inscho E W and Bost K L, 1999, Extracellular uridine nucleotides initiate cytokine production by murine dendritic cells. Cellular Immunology, vol.195(2): 147–156. http://dx.doi.org/10.1006/cimm.1999.153124. Idzko M, Panther E, Sorichter S, et al. 2004, Characterization of the biological activities of uridine diphosphate in human dendritic cells: influence on chemotaxis and CXCL8 release. Journal of Cellular Physiology, vol.201(2): 286–293. http://dx.doi.org/10.1002/jcp.2007025. Skelton L, Cooper M, Murphy M, et al. 2003, Human immature monocyte-derived dendritic cells express the G protein-coupled receptor GPR105 (KIAA0001, P2Y14) and increase intracellular calcium in response to its agonist, uridine diphosphoglucose. Journal of Immunology, vol.171(4): 1941–1949. http://dx.doi.org/10.4049/jimmunol.171.4.194126. Fricks I P, Maddileti S, Carter R L, et al. 2008, UDP is a competitive antagonist at the human P2Y14 receptor. Journal of Pharmacology and Experimental Therapeutics, vol.325(2): 588–594. http://dx.doi.org/10.1124/jpet.108.13630927. Carter R L, Fricks I P, Barrett M O, et al. 2009, Quantification of Gi-mediated inhibition of adenylyl cyclase activity reveals that UDP is a potent agonist of the human P2Y14 receptor. Molecular Pharmacology, vol.76(6): 1341–1348. http://dx.doi.org/10.1124/mol.109.05857828. Shin A, Toy T, Rothenfusser S, et al. 2008, P2Y receptor signaling regulates phenotype and IFN-alpha secretion of human plasmacytoid dendritic cells. Blood, vol.111: 3062–3069. http://dx.doi.org/10.1182/blood-2007-02-07191029. Mao C, Wang S, Xiao Y, et al. 2011, Impairment of regulatory capacity of CD4+CD25+ regulatory T cells mediated by dendritic cell polarization and hyperthyroidism in Graves’ disease. Journal of Immunology, vol.186(8): 4734–4743. http://dx.doi.org/10.4049/jimmunol.090413530. Somers G R, Hammet F M, Trute L, et al. 1998, Expression of the P2Y6 purinergic receptor in human T cells infiltrating inflammatory bowel disease. Laboratory Investigation, vol.78(11): 1375–1383. http://dx.doi.org/10.1084/jem.78.11.137531. Giannattasio G, Ohta S, Boyce J R, et al. 2011, The purinergic G protein-coupled receptor 6 inhibits effector T cell activation in allergic pulmonary inflammation. Journal of Immunology, vol.187(3): 1486–1495. http://dx.doi.org/10.4049/jimmunol.100366932. Tsukimoto M, Tokunaga A, Harada H, et al. 2009, Blockade of murine T cell activation by antagonists of P2Y6 and P2X7 receptors. Biochemical Biophysical Research Communication, vol.384(4): 512–518. http://dx.doi.org/10.1016/j.bbrc.2009.05.01133. Inaba K, Inaba M, Romani N, et al. 1992, Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. Journal of Experimental Medicine, vol.176(6): 1693–1702. http://dx.doi.org/10.1084/jem.176.6.169334. Ben Addi A, Lefort A, Hua X, et al. 2008, Modulation of murine dendritic cell function by adenine nucleotides and adenosine: involvement of the A(2B) receptor. European Journal of Immunology, vol.38(6): 1610–1620. http://dx.doi.org/10.1002/eji.20073778135. Norbury C C, 2006, Drinking a lot is good for dendritic cells. Immunology, vol.117(4): 443–451. http://dx.doi.org/10.1111/j.1365-2567.2006.02335.x36. Burgdorf S, Kautz A, Böhnert V, et al. 2007, Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation. Science, vol.316(5824): 612–616. http://dx.doi.org/10.1126/science.113797137. Marteau F, Communi D, Boeynaems J M, et al. 2004, Involvement of multiple P2Y receptors and signaling pathways in the action of adenine nucleotides diphosphates on human monocyte-derived dendritic cells. Journal of Leukocyte Biology, vol.76(4): 796–803. http://dx.doi.org/10.1189/jlb.010403238. Wilkin F, Duhant X, Bruyns C, et al. 2001, The P2Y11 receptor mediates the ATP-induced maturation of human monocyte-derived dendritic cells. Journal of Immunology, vol.166(12): 7172–7177. http://dx.doi.org/10.4049/jimmunol.166.12.717239. Wilkin F, Stordeur P, Goldman M, et al. 2002, Extracellular adenine nucleotides modulate cytokine production by human monocyte-derived dendritic cells: dual effect on IL-12 and stimulation of IL-10. European Journal of Immunology, vol.32(9): 2409–2417. http://dx.doi.org/10.1002/1521-4141(200209)32:9%3C2409::AID-IMMU2409%3E3.0.CO;2-H40. Müller T, Robaye B, Vieira R P, et al. 2010, The purinergic receptor P2Y2 receptor mediates chemotaxis of dendritic cells and eosinophils in allergic lung inflammation. Allergy, vol.65(12): 1545–1553. http://dx.doi.org/10.1111/j.1398-9995.2010.02426.x41. Pizzirani C, Ferrari D, Chiozzi P, et al. 2007, Stimulation of P2 receptors causes release of IL-1β-loaded microvesicles from human dendritic cells. Blood, vol.109: 3856–3864. http://dx.doi.org/10.1182/blood-2005-06-03137742. Weber F C, Esser P R, Müller T, et al. 2010, Lack of the purinergic receptor P2X7 results in resistance to contact hypersensitivity. Journal of Experimental Medicine, vol.207(12): 2609–2619. http://dx.doi.org/10.1084/jem.2009248943. Cunningham A F, Khan M, Ball J, et al. 2004, Responses to the soluble flagellar protein FliC are Th2, while those to FliC on Salmonella are Th1. European Journal of Immunology, vol.34(11): 2986–2995. http://dx.doi.org/10.1002/eji.200425403